Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD

Inclusion Criteria:

- Willing and able to adhere to the treatment schedule and all required study visits.

- Any non-Active Duty Military are included.

- PCL-M > 45

- Primary diagnosis of Posttraumatic Stress Disorder rendered by the Clinician
Administered PTSD Scale (CAPS)

Exclusion Criteria:

- Individuals diagnosed by the Investigator with the following conditions (current
unless otherwise stated): History of open skull traumatic brain injury. History of
clinically significant seizure disorder.

- Individuals with a clinically defined neurological disorder including, but not
limited to: Any condition likely to be associated with increased intracranial
pressure. Space occupying brain lesion. History of cerebrovascular accident. Cerebral
aneurysm.

- EEG abnormalities that indicate risk of seizure, i.e., abnormal focal or general
slowing or spikes during the EEG recording.

- Any type of rTMS treatment within 3 months prior to the screening visit.

- Currently under antipsychotic medication treatment.

- Intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants,
stents, or electrodes) or any other metal object within or near the head, excluding
the mouth, which cannot be safely removed.

- Clinically significant abnormality or clinically significant unstable medical
condition that in the Investigator's judgment might pose a potential safety risk to
the subject or limit interpretation of the trial results.

- Clinically significant medical illness, including any uncontrolled thyroid disorders,
hepatic, cardiac, pulmonary and renal malfunctioning.

- Any condition which in the judgment of the investigator would prevent the subject
from completion of the study.

- Inability to acquire a clinically satisfactory EEG/ECG on a routine basis.

- Grossly abnormal electrolyte or cell blood count panels suggestive of other pathology
at study initiation.

- Active Duty Military are excluded.